South Africa takes part in pediatric study of China's Sinovac vaccine

Download

02:11

South Africa and Kenya are part of a global pediatric trial of China's Sinovac jabs. South Africa on Friday started vaccinating some children and adolescents as part of the global Phase 3 clinical trials of China's Sinovac Biotech COVID-19 vaccine for children aged between six months and 17 years.

Open in CGTN APP for better experience

Search Trends